

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tolerance induction (GO:0002507) | 7.46997645 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.45778382 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.24671846 |
| 4 | leukocyte aggregation (GO:0070486) | 6.21992178 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.87012844 |
| 6 | negative T cell selection (GO:0043383) | 5.81119433 |
| 7 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.70763261 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.69628557 |
| 9 | regulation of regulatory T cell differentiation (GO:0045589) | 5.66620310 |
| 10 | DNA deamination (GO:0045006) | 5.53191314 |
| 11 | cytidine metabolic process (GO:0046087) | 5.26888902 |
| 12 | cytidine catabolic process (GO:0006216) | 5.26888902 |
| 13 | cytidine deamination (GO:0009972) | 5.26888902 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.23978142 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.17110449 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 4.97372502 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.96866428 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.96866428 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.94848492 |
| 20 | response to interleukin-15 (GO:0070672) | 4.89046128 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85609905 |
| 22 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.85506586 |
| 23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.79643362 |
| 24 | thymic T cell selection (GO:0045061) | 4.76960233 |
| 25 | hepatocyte apoptotic process (GO:0097284) | 4.76337947 |
| 26 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.69586254 |
| 27 | T cell selection (GO:0045058) | 4.63256494 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 4.62088085 |
| 29 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.49411692 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.49410868 |
| 31 | endothelial tube morphogenesis (GO:0061154) | 4.38448078 |
| 32 | morphogenesis of an endothelium (GO:0003159) | 4.38448078 |
| 33 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.36205437 |
| 34 | positive T cell selection (GO:0043368) | 4.31499337 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.26191176 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 4.16566239 |
| 37 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.16318377 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 4.10653204 |
| 39 | positive thymic T cell selection (GO:0045059) | 3.99039635 |
| 40 | T cell receptor signaling pathway (GO:0050852) | 3.96291589 |
| 41 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.93447418 |
| 42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.86322568 |
| 43 | microtubule severing (GO:0051013) | 3.80133696 |
| 44 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.77264557 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 3.76372641 |
| 46 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.76142310 |
| 47 | positive regulation of T cell mediated immunity (GO:0002711) | 3.69865294 |
| 48 | positive regulation of cell killing (GO:0031343) | 3.69434221 |
| 49 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.69287258 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.61773028 |
| 51 | alpha-beta T cell differentiation (GO:0046632) | 3.60663711 |
| 52 | positive regulation of interleukin-2 production (GO:0032743) | 3.59126049 |
| 53 | activated T cell proliferation (GO:0050798) | 3.58406271 |
| 54 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.56066348 |
| 55 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.54299866 |
| 56 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.54242198 |
| 57 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.54242198 |
| 58 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.53175386 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.52781205 |
| 60 | negative regulation of B cell activation (GO:0050869) | 3.52528336 |
| 61 | T cell migration (GO:0072678) | 3.50484757 |
| 62 | negative regulation of adaptive immune response (GO:0002820) | 3.49610801 |
| 63 | regulation of cell killing (GO:0031341) | 3.47987802 |
| 64 | regulation of tolerance induction (GO:0002643) | 3.46383564 |
| 65 | T cell differentiation involved in immune response (GO:0002292) | 3.45702887 |
| 66 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.45702887 |
| 67 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.45702887 |
| 68 | T-helper cell differentiation (GO:0042093) | 3.44146105 |
| 69 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.44146105 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 3.43812139 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.41742251 |
| 72 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.36531022 |
| 73 | positive regulation of isotype switching (GO:0045830) | 3.33279607 |
| 74 | positive regulation of cell fate commitment (GO:0010455) | 3.29277606 |
| 75 | alpha-beta T cell activation (GO:0046631) | 3.27568942 |
| 76 | regulation of T cell mediated immunity (GO:0002709) | 3.25722372 |
| 77 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.23333305 |
| 78 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.22803707 |
| 79 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.22717539 |
| 80 | mast cell activation (GO:0045576) | 3.21697365 |
| 81 | positive regulation of DNA recombination (GO:0045911) | 3.17668222 |
| 82 | T cell differentiation (GO:0030217) | 3.17338002 |
| 83 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.16930012 |
| 84 | interferon-gamma production (GO:0032609) | 3.16831523 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 3.14817878 |
| 86 | regulation of B cell differentiation (GO:0045577) | 3.13899968 |
| 87 | regulation of alpha-beta T cell activation (GO:0046634) | 3.12585535 |
| 88 | lymph node development (GO:0048535) | 3.12299182 |
| 89 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.12038638 |
| 90 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.10648939 |
| 91 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.08597479 |
| 92 | regulation of fibroblast apoptotic process (GO:2000269) | 3.03300300 |
| 93 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.02851309 |
| 94 | regulation of interleukin-2 production (GO:0032663) | 3.02660605 |
| 95 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.01923123 |
| 96 | positive regulation of B cell mediated immunity (GO:0002714) | 3.01923123 |
| 97 | T cell homeostasis (GO:0043029) | 3.00656058 |
| 98 | regulation of isotype switching (GO:0045191) | 3.00653061 |
| 99 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99202651 |
| 100 | Peyers patch development (GO:0048541) | 2.99202651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.99941347 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.77841786 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59134031 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.21260900 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.56984184 |
| 6 | MYB_26560356_Chip-Seq_TH2_Human | 3.50858373 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.41548979 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.41168979 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.32549542 |
| 10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.03711347 |
| 11 | MYB_26560356_Chip-Seq_TH1_Human | 2.94841517 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.92561643 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80999855 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.64440052 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62201417 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57529445 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.41506684 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.40747581 |
| 19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.22717625 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20659545 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 2.12993967 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08135373 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 2.06213249 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02761442 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94433623 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.90970009 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88795512 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86067800 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84478444 |
| 30 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.83433794 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.78284345 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76088521 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76073073 |
| 34 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.70933130 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69947118 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68920081 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66331660 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58289053 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56954721 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.53130270 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43047372 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41719286 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41465054 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37710023 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.33430745 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33266629 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27579638 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27383821 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27122597 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26774896 |
| 51 | GATA3_26560356_Chip-Seq_TH1_Human | 1.24162703 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23718457 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22158757 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18324573 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16743606 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10973648 |
| 57 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07272938 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05071859 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04213707 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01314171 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01057828 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99224092 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98120644 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97904086 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97451790 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96448534 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95660622 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94794938 |
| 69 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.94628421 |
| 70 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.94628421 |
| 71 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.94628421 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94612156 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93863489 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93794988 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93764165 |
| 76 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93580444 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93505709 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92343277 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88937643 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88633405 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86835043 |
| 82 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86371140 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84184779 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83408502 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82993260 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82900203 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82355532 |
| 88 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.80792019 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80188395 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79020169 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.77080597 |
| 92 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.76474195 |
| 93 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74992216 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.74525427 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.74395880 |
| 96 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74092611 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.73634156 |
| 98 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.73470895 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73461159 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.73359070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.93845585 |
| 2 | MP0005671_abnormal_response_to | 4.16513087 |
| 3 | MP0003436_decreased_susceptibility_to | 3.92919758 |
| 4 | MP0001790_abnormal_immune_system | 3.31404983 |
| 5 | MP0005387_immune_system_phenotype | 3.31404983 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.25380919 |
| 7 | MP0001800_abnormal_humoral_immune | 3.16209512 |
| 8 | MP0001873_stomach_inflammation | 3.10800259 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.93040358 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.88388213 |
| 11 | MP0000685_abnormal_immune_system | 2.87991180 |
| 12 | MP0003724_increased_susceptibility_to | 2.85275702 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.81219389 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.76525039 |
| 15 | MP0002723_abnormal_immune_serum | 2.55914010 |
| 16 | MP0009785_altered_susceptibility_to | 2.51729332 |
| 17 | MP0003866_abnormal_defecation | 2.38670439 |
| 18 | MP0004381_abnormal_hair_follicle | 2.37096782 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.35375331 |
| 20 | MP0001819_abnormal_immune_cell | 2.32899285 |
| 21 | MP0000703_abnormal_thymus_morphology | 2.29916401 |
| 22 | MP0005025_abnormal_response_to | 2.26661680 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.26567987 |
| 24 | MP0002405_respiratory_system_inflammati | 2.18490042 |
| 25 | MP0002398_abnormal_bone_marrow | 2.15893209 |
| 26 | MP0002009_preneoplasia | 2.14454177 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 2.09761446 |
| 28 | MP0000716_abnormal_immune_system | 1.98487412 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.92871952 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.89240437 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.88528870 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.81100520 |
| 33 | MP0005310_abnormal_salivary_gland | 1.80887238 |
| 34 | MP0004947_skin_inflammation | 1.79927392 |
| 35 | MP0002722_abnormal_immune_system | 1.79763141 |
| 36 | MP0002419_abnormal_innate_immunity | 1.75872085 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.71603839 |
| 38 | MP0002102_abnormal_ear_morphology | 1.70407638 |
| 39 | MP0000490_abnormal_crypts_of | 1.66478571 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.55341835 |
| 41 | MP0003878_abnormal_ear_physiology | 1.55341835 |
| 42 | MP0002429_abnormal_blood_cell | 1.54460142 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.53042612 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.51625222 |
| 45 | MP0006082_CNS_inflammation | 1.48963063 |
| 46 | MP0001348_abnormal_lacrimal_gland | 1.48419330 |
| 47 | MP0002163_abnormal_gland_morphology | 1.47820149 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.39094657 |
| 49 | MP0000371_diluted_coat_color | 1.31824585 |
| 50 | MP0003303_peritoneal_inflammation | 1.31622558 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.30279599 |
| 52 | MP0008260_abnormal_autophagy | 1.24523769 |
| 53 | MP0002006_tumorigenesis | 1.23328334 |
| 54 | MP0002933_joint_inflammation | 1.18353832 |
| 55 | MP0001663_abnormal_digestive_system | 1.17350014 |
| 56 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16873211 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.13125702 |
| 58 | MP0008057_abnormal_DNA_replication | 1.11928832 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.07482964 |
| 60 | MP0008469_abnormal_protein_level | 1.05709082 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.00304304 |
| 62 | MP0003448_altered_tumor_morphology | 0.97031870 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 0.95820959 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.86742671 |
| 65 | MP0002693_abnormal_pancreas_physiology | 0.85838834 |
| 66 | MP0000858_altered_metastatic_potential | 0.85567109 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 0.83778989 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.83276657 |
| 69 | MP0001853_heart_inflammation | 0.81893654 |
| 70 | MP0005076_abnormal_cell_differentiation | 0.81137426 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 0.79182176 |
| 72 | MP0001765_abnormal_ion_homeostasis | 0.78017724 |
| 73 | MP0000604_amyloidosis | 0.74561227 |
| 74 | MP0001851_eye_inflammation | 0.73096405 |
| 75 | MP0009764_decreased_sensitivity_to | 0.72850967 |
| 76 | MP0001346_abnormal_lacrimal_gland | 0.72710105 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.69095269 |
| 78 | MP0001919_abnormal_reproductive_system | 0.67510014 |
| 79 | MP0005381_digestive/alimentary_phenotyp | 0.65782654 |
| 80 | MP0002132_abnormal_respiratory_system | 0.63426924 |
| 81 | MP0005390_skeleton_phenotype | 0.63399564 |
| 82 | MP0003943_abnormal_hepatobiliary_system | 0.61977928 |
| 83 | MP0009763_increased_sensitivity_to | 0.61913323 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.61432242 |
| 85 | MP0001216_abnormal_epidermal_layer | 0.57357689 |
| 86 | MP0003950_abnormal_plasma_membrane | 0.57275383 |
| 87 | MP0003045_fibrosis | 0.56878902 |
| 88 | MP0004742_abnormal_vestibular_system | 0.55906695 |
| 89 | MP0005365_abnormal_bile_salt | 0.52706902 |
| 90 | MP0001879_abnormal_lymphatic_vessel | 0.51923506 |
| 91 | MP0000609_abnormal_liver_physiology | 0.51367494 |
| 92 | MP0008872_abnormal_physiological_respon | 0.49815044 |
| 93 | MP0001243_abnormal_dermal_layer | 0.48762019 |
| 94 | MP0001191_abnormal_skin_condition | 0.48180343 |
| 95 | MP0000477_abnormal_intestine_morphology | 0.47513332 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.46891151 |
| 97 | MP0003795_abnormal_bone_structure | 0.46353566 |
| 98 | MP0005408_hypopigmentation | 0.46133037 |
| 99 | MP0001188_hyperpigmentation | 0.45281856 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.44899475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.67498343 |
| 2 | Autoimmune hemolytic anemia (HP:0001890) | 6.27885542 |
| 3 | Increased IgM level (HP:0003496) | 5.88331138 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.34137246 |
| 5 | IgG deficiency (HP:0004315) | 4.84926033 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.82864397 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.39946760 |
| 8 | T lymphocytopenia (HP:0005403) | 4.27398050 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 4.27157523 |
| 10 | Abnormality of T cells (HP:0002843) | 4.07245162 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.94128689 |
| 12 | Pulmonary infiltrates (HP:0002113) | 3.94090395 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 3.83152185 |
| 14 | Myositis (HP:0100614) | 3.77936660 |
| 15 | IgM deficiency (HP:0002850) | 3.74000299 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.63862116 |
| 17 | Abnormality of T cell physiology (HP:0011840) | 3.63626889 |
| 18 | Abnormality of eosinophils (HP:0001879) | 3.43251373 |
| 19 | Vasculitis (HP:0002633) | 3.42125092 |
| 20 | Joint swelling (HP:0001386) | 3.41395630 |
| 21 | Abnormality of the prostate (HP:0008775) | 3.40810044 |
| 22 | Adactyly (HP:0009776) | 3.40683939 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.21424753 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.18949674 |
| 25 | Optic neuritis (HP:0100653) | 3.18949674 |
| 26 | Eosinophilia (HP:0001880) | 3.17684776 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.13753883 |
| 28 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.06759329 |
| 29 | Abnormality of the pons (HP:0007361) | 3.05138417 |
| 30 | Granulocytopenia (HP:0001913) | 3.04958247 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.04822802 |
| 32 | Meningitis (HP:0001287) | 3.03895722 |
| 33 | Obstructive lung disease (HP:0006536) | 2.99701171 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99701171 |
| 35 | Leukocytosis (HP:0001974) | 2.96808826 |
| 36 | Orchitis (HP:0100796) | 2.93634191 |
| 37 | Lymphopenia (HP:0001888) | 2.90283459 |
| 38 | Encephalitis (HP:0002383) | 2.89534022 |
| 39 | Pustule (HP:0200039) | 2.84641853 |
| 40 | Porencephaly (HP:0002132) | 2.84391732 |
| 41 | Recurrent viral infections (HP:0004429) | 2.84174081 |
| 42 | Hypochromic anemia (HP:0001931) | 2.79054019 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.78330879 |
| 44 | Pulmonary fibrosis (HP:0002206) | 2.73457217 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.72551586 |
| 46 | Chest pain (HP:0100749) | 2.70621646 |
| 47 | Hemoptysis (HP:0002105) | 2.69974451 |
| 48 | Combined immunodeficiency (HP:0005387) | 2.69094777 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.65617170 |
| 50 | Gangrene (HP:0100758) | 2.64752611 |
| 51 | B lymphocytopenia (HP:0010976) | 2.59780454 |
| 52 | Chronic diarrhea (HP:0002028) | 2.59167814 |
| 53 | Alveolar cell carcinoma (HP:0006519) | 2.55118199 |
| 54 | Hypoplasia of the pons (HP:0012110) | 2.50841571 |
| 55 | Pulmonary embolism (HP:0002204) | 2.49433643 |
| 56 | Impaired proprioception (HP:0010831) | 2.49122408 |
| 57 | Thyroiditis (HP:0100646) | 2.47562812 |
| 58 | Genetic anticipation (HP:0003743) | 2.46549819 |
| 59 | Lymphoma (HP:0002665) | 2.44407810 |
| 60 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.40036060 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.38205444 |
| 62 | Acute hepatic failure (HP:0006554) | 2.36982249 |
| 63 | Stomach cancer (HP:0012126) | 2.35656114 |
| 64 | Axonal loss (HP:0003447) | 2.35353057 |
| 65 | Testicular atrophy (HP:0000029) | 2.34581157 |
| 66 | Abnormality of macrophages (HP:0004311) | 2.34460539 |
| 67 | Ureteral stenosis (HP:0000071) | 2.31106658 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.27303018 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.22653825 |
| 70 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.21340469 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.21305408 |
| 72 | Anorexia (HP:0002039) | 2.20792864 |
| 73 | Absent hand (HP:0004050) | 2.20295597 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.18794384 |
| 75 | Papilledema (HP:0001085) | 2.15061399 |
| 76 | Urticaria (HP:0001025) | 2.13302919 |
| 77 | Ureteral obstruction (HP:0006000) | 2.11065803 |
| 78 | Aplastic anemia (HP:0001915) | 2.10557959 |
| 79 | Dyschromatopsia (HP:0007641) | 2.09236443 |
| 80 | Keratoconjunctivitis (HP:0001096) | 2.06252623 |
| 81 | Diplopia (HP:0000651) | 2.04555049 |
| 82 | Abnormality of binocular vision (HP:0011514) | 2.04555049 |
| 83 | Hypoproteinemia (HP:0003075) | 2.04454746 |
| 84 | Metaphyseal dysplasia (HP:0100255) | 2.03360820 |
| 85 | Arterial thrombosis (HP:0004420) | 2.02266100 |
| 86 | Glomerulopathy (HP:0100820) | 2.00400031 |
| 87 | Syringomyelia (HP:0003396) | 1.98179449 |
| 88 | Spinal cord lesions (HP:0100561) | 1.98179449 |
| 89 | Hypochromic microcytic anemia (HP:0004840) | 1.95827682 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95707937 |
| 91 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95707937 |
| 92 | Inflammation of the large intestine (HP:0002037) | 1.92338992 |
| 93 | Epistaxis (HP:0000421) | 1.90168016 |
| 94 | Pancytopenia (HP:0001876) | 1.88758283 |
| 95 | Cortical visual impairment (HP:0100704) | 1.88535350 |
| 96 | Abnormality of dental color (HP:0011073) | 1.88303023 |
| 97 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.87976752 |
| 98 | Polyneuropathy (HP:0001271) | 1.86843298 |
| 99 | Deep palmar crease (HP:0006191) | 1.86750275 |
| 100 | Abnormality of male internal genitalia (HP:0000022) | 1.82034600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.88890245 |
| 2 | MST4 | 5.22796797 |
| 3 | MAP4K1 | 5.03872360 |
| 4 | SIK3 | 4.71154557 |
| 5 | TRIM28 | 2.31363140 |
| 6 | DAPK2 | 2.28705995 |
| 7 | TSSK6 | 2.27555076 |
| 8 | PIK3CG | 2.23566311 |
| 9 | MAP3K14 | 2.19069744 |
| 10 | ITK | 2.16903591 |
| 11 | TAF1 | 2.10342866 |
| 12 | MAP3K13 | 1.97627245 |
| 13 | BCR | 1.95865635 |
| 14 | IKBKE | 1.90602512 |
| 15 | CSK | 1.86294541 |
| 16 | GRK6 | 1.71510430 |
| 17 | FES | 1.68191604 |
| 18 | BTK | 1.63275924 |
| 19 | TYK2 | 1.58396814 |
| 20 | LCK | 1.54029629 |
| 21 | MAP3K11 | 1.53888444 |
| 22 | SYK | 1.47171511 |
| 23 | JAK3 | 1.46201932 |
| 24 | TEC | 1.44770593 |
| 25 | PASK | 1.43822994 |
| 26 | NLK | 1.42700177 |
| 27 | RIPK4 | 1.39022718 |
| 28 | FGFR3 | 1.37650067 |
| 29 | DYRK2 | 1.36099565 |
| 30 | HCK | 1.27182225 |
| 31 | ZAP70 | 1.25534821 |
| 32 | JAK1 | 1.23343158 |
| 33 | CDK8 | 1.22642911 |
| 34 | TNK2 | 1.22080264 |
| 35 | IKBKB | 1.21312480 |
| 36 | SIK2 | 1.18539026 |
| 37 | PRKCQ | 1.15254122 |
| 38 | MAPK11 | 1.10595392 |
| 39 | LYN | 1.08391120 |
| 40 | MAP3K12 | 1.02661659 |
| 41 | MAP2K3 | 0.96559551 |
| 42 | MARK3 | 0.93973534 |
| 43 | TAOK3 | 0.87628023 |
| 44 | FGFR4 | 0.87288981 |
| 45 | CAMKK2 | 0.85629367 |
| 46 | TAOK1 | 0.85565186 |
| 47 | DAPK1 | 0.81553142 |
| 48 | IRAK4 | 0.80102539 |
| 49 | PRPF4B | 0.79325691 |
| 50 | MAPKAPK2 | 0.78456896 |
| 51 | TBK1 | 0.76303854 |
| 52 | SCYL2 | 0.74535360 |
| 53 | MAP3K9 | 0.71860386 |
| 54 | JAK2 | 0.67288190 |
| 55 | BLK | 0.67108263 |
| 56 | PDK1 | 0.63960693 |
| 57 | PIM1 | 0.63401644 |
| 58 | EPHA3 | 0.60337651 |
| 59 | EPHB1 | 0.58033857 |
| 60 | CSF1R | 0.54480680 |
| 61 | PDK2 | 0.53677381 |
| 62 | STK10 | 0.51510863 |
| 63 | MAP3K1 | 0.48879517 |
| 64 | CAMKK1 | 0.48715473 |
| 65 | MAP2K6 | 0.48170827 |
| 66 | VRK2 | 0.47233870 |
| 67 | CHUK | 0.45928281 |
| 68 | FYN | 0.45673451 |
| 69 | MELK | 0.43281354 |
| 70 | MAP3K5 | 0.41944902 |
| 71 | CASK | 0.39987661 |
| 72 | NEK6 | 0.39309129 |
| 73 | KSR1 | 0.39177963 |
| 74 | ADRBK2 | 0.37706352 |
| 75 | PTK2B | 0.36199299 |
| 76 | ALK | 0.35867507 |
| 77 | RPS6KB1 | 0.35613439 |
| 78 | IGF1R | 0.34606610 |
| 79 | STK39 | 0.33364085 |
| 80 | TYRO3 | 0.33026806 |
| 81 | HIPK2 | 0.32153720 |
| 82 | SIK1 | 0.30898739 |
| 83 | RPS6KA4 | 0.30150788 |
| 84 | WNK4 | 0.30015495 |
| 85 | EIF2AK3 | 0.29692494 |
| 86 | PRKCD | 0.26870764 |
| 87 | NUAK1 | 0.26755195 |
| 88 | MAP3K3 | 0.26647108 |
| 89 | MAPK9 | 0.25213701 |
| 90 | SMG1 | 0.24954654 |
| 91 | KIT | 0.24877939 |
| 92 | TAOK2 | 0.24602584 |
| 93 | CAMK1D | 0.24442898 |
| 94 | PRKD2 | 0.21975831 |
| 95 | STK4 | 0.21783613 |
| 96 | OXSR1 | 0.21447762 |
| 97 | DAPK3 | 0.21412244 |
| 98 | MARK2 | 0.21009622 |
| 99 | CSNK1A1L | 0.19750353 |
| 100 | SGK2 | 0.18441169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.47077674 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.97245412 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.15849596 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.14882812 |
| 5 | Measles_Homo sapiens_hsa05162 | 3.07412801 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.91331880 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.82494448 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.52547879 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44628109 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.34845341 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34643803 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.23877057 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15558095 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05074754 |
| 15 | RNA degradation_Homo sapiens_hsa03018 | 2.01305782 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95788686 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74922492 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74719633 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61148564 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58337581 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.54230163 |
| 22 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.53287851 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50245277 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.44839733 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44781469 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.44670614 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42178431 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41958317 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.39836492 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39391038 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37503453 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.36992097 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31935803 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31142360 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.28269804 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24694264 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.18546577 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10806523 |
| 39 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09434192 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08528323 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.07623621 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06852466 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.04532217 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.01693489 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00172078 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98368961 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95467040 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94708873 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92744403 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.90389571 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81297442 |
| 52 | Protein export_Homo sapiens_hsa03060 | 0.81016408 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77877180 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.77597286 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.76939384 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71592273 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71160374 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69174690 |
| 59 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68741516 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68633723 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67193011 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66820728 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63872327 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63516340 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59888202 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54973631 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52635701 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51730777 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49677298 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.49237640 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39563694 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39263219 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37813237 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37395254 |
| 75 | RNA transport_Homo sapiens_hsa03013 | 0.35942742 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35520502 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35129477 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34785851 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32154713 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31803596 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.31351650 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30169587 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.29319859 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27635337 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26221681 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.25414531 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23654315 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23592049 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23072925 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.22839815 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22776259 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22754145 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.21763611 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.21148847 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18404161 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16616004 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.15489928 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14804720 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13790075 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13297214 |

